Trending Stock News

Ardevora Asset Management Llp Raised Its Regeneron Pharmaceuticals (REGN) Holding by $8.10 Million; Stock Declined; Us Bancorp Del (USB) Shareholder D-Scott Neal Decreased Its Holding

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Logo

Ardevora Asset Management Llp increased its stake in Regeneron Pharmaceuticals (REGN) by 38.5% based on its latest 2017Q4 regulatory filing with the SEC. Ardevora Asset Management Llp bought 21,600 shares as the company’s stock declined 13.59% with the market. The institutional investor held 77,700 shares of the health care company at the end of 2017Q4, valued at $29.21M, up from 56,100 at the end of the previous reported quarter. Ardevora Asset Management Llp who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be bullish on the $33.81B market cap company. The stock decreased 0.50% or $1.58 during the last trading session, reaching $314.25. About 688,735 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has declined 14.19% since April 23, 2017 and is downtrending. It has underperformed by 25.74% the S&P500.

D-Scott Neal Inc decreased its stake in Us Bancorp Del (USB) by 86.77% based on its latest 2017Q4 regulatory filing with the SEC. D-Scott Neal Inc sold 6,559 shares as the company’s stock declined 8.45% with the market. The institutional investor held 1,000 shares of the major banks company at the end of 2017Q4, valued at $54,000, down from 7,559 at the end of the previous reported quarter. D-Scott Neal Inc who had been investing in Us Bancorp Del for a number of months, seems to be less bullish one the $83.25B market cap company. The stock decreased 0.53% or $0.27 during the last trading session, reaching $50.43. About 7.93M shares traded or 9.23% up from the average. U.S. Bancorp (NYSE:USB) has declined 4.48% since April 23, 2017 and is downtrending. It has underperformed by 16.03% the S&P500.

Among 33 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 12 have Buy rating, 1 Sell and 20 Hold. Therefore 36% are positive. Regeneron Pharmaceuticals Inc. had 122 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was initiated by Bernstein on Wednesday, June 29 with “Outperform”. As per Tuesday, November 28, the company rating was maintained by BTIG Research. The firm has “Buy” rating by BTIG Research given on Friday, June 30. The stock has “Buy” rating by Piper Jaffray on Thursday, September 28. Credit Suisse downgraded the stock to “Hold” rating in Friday, July 14 report. The firm earned “Buy” rating on Monday, August 31 by RBC Capital Markets. The rating was initiated by Evercore with “Buy” on Wednesday, August 16. The firm earned “Buy” rating on Monday, September 18 by Credit Suisse. As per Friday, February 9, the company rating was downgraded by BTIG Research. The firm has “Market Perform” rating given on Wednesday, July 22 by Northland Capital.

Since February 9, 2018, it had 0 insider purchases, and 3 selling transactions for $1.71 million activity.

Investors sentiment is 1.17 in Q4 2017. Its the same as in 2017Q3. It is the same, as 62 investors sold REGN shares while 161 reduced holdings. only 71 funds opened positions while 191 raised stakes. 69.17 million shares or 6.15% less from 73.70 million shares in 2017Q3 were reported. First Allied Advisory Svcs invested in 2,208 shares or 0.03% of the stock. Steinberg Glob Asset Mngmt accumulated 0.07% or 1,282 shares. Cubist Systematic Strategies Ltd Llc accumulated 11,540 shares or 0.23% of the stock. State Teachers Retirement Sys reported 120,855 shares or 0.11% of all its holdings. Northern Trust Corporation reported 935,209 shares. Bessemer Group Inc reported 373 shares or 0% of all its holdings. Greenleaf Tru has 0% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 43 shares. Joel Isaacson & Co Limited Liability Corporation reported 0.2% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Smithfield Trust owns 76 shares for 0% of their portfolio. Fmr Lc holds 5.63 million shares or 0.25% of its portfolio. Savings Bank Of Nova Scotia owns 25,253 shares for 0.04% of their portfolio. Atria Ltd Limited Liability Company stated it has 0.04% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). The Washington-based Cornerstone Advisors has invested 0.16% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Macquarie Gp holds 0.04% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 54,124 shares. Reilly Fincl Advsr Ltd holds 3 shares.

Ardevora Asset Management Llp, which manages about $3.33 billion US Long portfolio, decreased its stake in Unitedhealth Group Inc (NYSE:UNH) by 33,100 shares to 117,435 shares, valued at $25.89 million in 2017Q4, according to the filing. It also reduced its holding in Chemours Co by 72,500 shares in the quarter, leaving it with 724,800 shares, and cut its stake in Sherwin Williams Co (NYSE:SHW).

Among 33 analysts covering U.S. Bancorp (NYSE:USB), 11 have Buy rating, 4 Sell and 18 Hold. Therefore 33% are positive. U.S. Bancorp had 95 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Keefe Bruyette & Woods on Wednesday, April 18 with “Hold”. The firm has “Buy” rating given on Friday, September 15 by Jefferies. The rating was maintained by Wells Fargo with “Market Perform” on Thursday, August 10. The firm has “Hold” rating by Keefe Bruyette & Woods given on Friday, October 13. The firm has “Buy” rating by Jefferies given on Thursday, June 8. On Thursday, December 1 the stock rating was downgraded by Susquehanna to “Neutral”. The firm has “Hold” rating by Keefe Bruyette & Woods given on Thursday, December 21. The stock has “Overweight” rating by Atlantic Securities on Monday, March 14. The firm earned “Market Perform” rating on Friday, May 5 by Wells Fargo. PiperJaffray downgraded the shares of USB in report on Wednesday, November 16 to “Neutral” rating.

D-Scott Neal Inc, which manages about $179.38M and $166.83 million US Long portfolio, upped its stake in Schwab Strategic Tr (SCHB) by 17,875 shares to 17,917 shares, valued at $1.16 million in 2017Q4, according to the filing. It also increased its holding in Spdr S&P Midcap 400 Etf (MDY) by 19,598 shares in the quarter, for a total of 93,497 shares, and has risen its stake in Schwab Strategic Tr (SCHX).

Investors sentiment increased to 0.96 in 2017 Q4. Its up 0.07, from 0.89 in 2017Q3. It is positive, as 38 investors sold USB shares while 462 reduced holdings. 118 funds opened positions while 361 raised stakes. 1.18 billion shares or 1.20% less from 1.20 billion shares in 2017Q3 were reported. Quantum Mgmt invested in 0.09% or 6,957 shares. Suffolk Management Limited Liability Corp has invested 0.04% in U.S. Bancorp (NYSE:USB). Hennessy Advisors has invested 0.03% in U.S. Bancorp (NYSE:USB). Brighton Jones Lc reported 0.21% in U.S. Bancorp (NYSE:USB). Riverpoint Mngmt Limited Liability Co holds 31,878 shares. Arrow Financial Corp accumulated 69,635 shares or 0.86% of the stock. Gw Henssler Associate Ltd stated it has 1.29% of its portfolio in U.S. Bancorp (NYSE:USB). Ariel Investments Lc has 0.23% invested in U.S. Bancorp (NYSE:USB) for 387,748 shares. Peak6 Investments LP owns 101,987 shares for 0.03% of their portfolio. Atlantic Trust Gp Ltd Limited Liability Company reported 0.63% of its portfolio in U.S. Bancorp (NYSE:USB). White Pine Cap Lc reported 21,904 shares or 0.43% of all its holdings. Ahl Prtn Limited Liability Partnership has invested 0.05% of its portfolio in U.S. Bancorp (NYSE:USB). Opus Invest stated it has 0.23% in U.S. Bancorp (NYSE:USB). Clifford Swan Counsel Lc has 0.04% invested in U.S. Bancorp (NYSE:USB) for 13,897 shares. Whittier Of Nevada holds 0.08% or 17,983 shares.

Since February 20, 2018, it had 0 buys, and 5 sales for $9.81 million activity. $1.35M worth of U.S. Bancorp (NYSE:USB) was sold by GODRIDGE LESLIE V. von Gillern Jeffry H. also sold $750,528 worth of U.S. Bancorp (NYSE:USB) shares. $5.51 million worth of stock was sold by Parker P.W. on Tuesday, February 20. On Friday, February 23 the insider Kelligrew James B sold $1.10M.

U.S. Bancorp (NYSE:USB) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *